Virax Biolabs Group Limited Asset Turnover Ratio (VRAX), as of fourth quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Virax Biolabs Group Limited  (NASDAQ: VRAX)
 

Virax Biolabs Group Limited Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Mar 31 2024, Virax Biolabs Group Limited has not recorded any assets.
Visit Virax Biolabs Group Limited Balance sheet

Within sector 13 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the IV Quarter 2024, to , from total ranking in the third quarter 2024 at 5057.

Asset Turnover Ratio Definition



VRAX Asset Turnover Ratio (Mar 31 2024)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter

Y / Y Asset Change -34.77 % -48.69 % 3219.14 % 1053.47 % -
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) - - - - -
VRAX's Total Ranking # # 5057 # # #
Seq. Asset Change 24.92 % -73.02 % 270.59 % -47.78 % -1.75 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 14
Healthcare Sector # 651
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0.03 0.01 0
(Mar 31 2024)   (Mar 31 2023)







Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2024 Assets at quarter ending Mar 31 2024



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.